These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1005 related items for PubMed ID: 18163505

  • 1. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, Mouthon L, Guillevin L, Meyer O, Ekindjian OG, Weber S, Kahan A.
    Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
    [Abstract] [Full Text] [Related]

  • 2. N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers.
    Allanore Y, Borderie D, Meune C, Cabanes L, Weber S, Ekindjian OG, Kahan A.
    Arthritis Rheum; 2003 Dec; 48(12):3503-8. PubMed ID: 14674001
    [Abstract] [Full Text] [Related]

  • 3. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG.
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [Abstract] [Full Text] [Related]

  • 4. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
    Cavagna L, Caporali R, Klersy C, Ghio S, Albertini R, Scelsi L, Moratti R, Bonino C, Montecucco C.
    J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
    [Abstract] [Full Text] [Related]

  • 5. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK, Wergeland R, Simonsen S, Geiran O, Guevara C, Ueland T.
    Am J Cardiol; 2006 Aug 15; 98(4):525-9. PubMed ID: 16893710
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock.
    Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettilä V, FINNSEPSIS Study Group.
    Crit Care Med; 2007 May 15; 35(5):1277-83. PubMed ID: 17414731
    [Abstract] [Full Text] [Related]

  • 9. Biological serum markers in the management of pediatric pulmonary arterial hypertension.
    Van Albada ME, Loot FG, Fokkema R, Roofthooft MT, Berger RM.
    Pediatr Res; 2008 Mar 15; 63(3):321-7. PubMed ID: 18287971
    [Abstract] [Full Text] [Related]

  • 10. Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.
    Mathai SC, Bueso M, Hummers LK, Boyce D, Lechtzin N, Le Pavec J, Campo A, Champion HC, Housten T, Forfia PR, Zaiman AL, Wigley FM, Girgis RE, Hassoun PM.
    Eur Respir J; 2010 Jan 15; 35(1):95-104. PubMed ID: 19643943
    [Abstract] [Full Text] [Related]

  • 11. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.
    Anesth Analg; 2009 Nov 15; 109(5):1403-8. PubMed ID: 19843778
    [Abstract] [Full Text] [Related]

  • 12. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C, Praino E, Nivuori M, di Serio F, Lapadula G, Iannone F.
    Int J Rheum Dis; 2017 Jan 15; 20(1):90-96. PubMed ID: 26218502
    [Abstract] [Full Text] [Related]

  • 13. C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease.
    Elstein D, Nir A, Klutstein M, Rudensky B, Zimran A.
    Blood Cells Mol Dis; 2005 Jan 15; 34(3):201-5. PubMed ID: 15885602
    [Abstract] [Full Text] [Related]

  • 14. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.
    Sir JJ, Chung WY, Hwang SJ, Kang HJ, Cho YS, Koo BK, Chae IH, Choi DJ, Kim HS, Sohn DW, Kim CH, Oh BH, Park YB, Choi YS.
    Int J Cardiol; 2008 Jun 06; 126(3):322-32. PubMed ID: 17544525
    [Abstract] [Full Text] [Related]

  • 15. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD.
    Circulation; 2010 Jul 13; 122(2):164-72. PubMed ID: 20585012
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease.
    Trad S, Amoura Z, Beigelman C, Haroche J, Costedoat N, Boutin le TH, Cacoub P, Frances C, Wechsler B, Grenier P, Piette JC.
    Arthritis Rheum; 2006 Jan 13; 54(1):184-91. PubMed ID: 16385514
    [Abstract] [Full Text] [Related]

  • 17. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
    Januzzi JL, Sakhuja R, O'donoghue M, Baggish AL, Anwaruddin S, Chae CU, Cameron R, Krauser DG, Tung R, Camargo CA, Lloyd-Jones DM.
    Arch Intern Med; 2006 Feb 13; 166(3):315-20. PubMed ID: 16476871
    [Abstract] [Full Text] [Related]

  • 18. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL.
    Eur Heart J; 2009 May 13; 30(9):1057-65. PubMed ID: 19168526
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S, Webb MC, Price CP, John RI, Abbas NA, Lamb EJ.
    Nephrol Dial Transplant; 2008 Nov 13; 23(11):3546-53. PubMed ID: 18562472
    [Abstract] [Full Text] [Related]

  • 20. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
    Coron Artery Dis; 2009 May 13; 20(3):219-24. PubMed ID: 19322079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.